This technical symposium is a unique opportunity to discover enabling technologies and today's trends in the broad field of pharmaceutical PEG applications, development, and processing.
Industry experts will present the latest progress in activated PEGs and conjugation chaired by Lisa McDermott from Merck.
During this symposium, you will:
- Learn about the next generation of protein PEGylation and PEG analytics
- Get perspectives on regulatory aspects for activated PEGs in pharmaceutical applications
- Discuss and tackle today’s PEG challenges with your peers
Speakers
Lisa McDermott
Merck
Director Process and Analytical Development
Lisa joined Merck in January 2010 as an analytical project lead, responsible for ADCs. She brings with her more than 25 years of experience in both organic synthesis and analytical sciences and has had the opportunity to contribute to many projects ranging from discovery to full development, but none has been as exciting as the emergence of ADCs. She also has an extensive chromatography background with experience in integrated LC/MS screening systems.
Lars Albermann, Ph.D.
Merck
Head of Pharma Registration and Regulatory Projects
Tobias Haag, Ph.D.
Merck
Head Process and Analytical Development, Schaffhausen
Marco Passafaro, Ph.D.
Merck
Senior Scientist, R&D Drug Delivery Compounds
Pharma and biopharma manufacturing
- Solid Formulation Strategies
期间:1h 40min
语言:English
场次 1:往期 June 17, 2021
如要继续阅读，请登录或创建帐户。
暂无帐户？